Anzeige
Mehr »
Mittwoch, 14.01.2026 - Börsentäglich über 12.000 News
Strategischer Schachzug: Germanium Mining sichert sich massives Flächenpotenzial im Kampf um die High-Tech-Vorherrschaft
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
156 Leser
Artikel bewerten:
(1)

Alira Health Announces Bill Achtmeyer and George G. Montgomery as Members of Board of Directors

FRAMINGHAM, Mass., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Alira Health, a global healthcare consultancy partnering with life sciences companies and patients to deliver evidence-based solutions, announced that Bill Achtmeyer and George G. Montgomery, MBA are serving as members of its Board of Directors. Mr. Montgomery was also elected Chairman of the Board.

Their service supports Alira Health's continued focus on advancing a differentiated, patient-centered model that integrates perspectives from those affected by disease into evidence generation, development strategy, access planning, and commercialization across the product lifecycle. Central to this approach are Alira Health's Patient-Enabled Solutions, which bring real-world insight into decision-making in a structured and scalable way.

Mr. Achtmeyer is the Chairman and Managing Partner of Acropolis Advisors, which he co-founded with Professor Michael Porter of Harvard Business School, and the former CEO and founder of The Parthenon Group, the global strategy consultancy that later merged with EY to form EY-Parthenon. He brings deep experience in strategy, governance, and the scaling of professional services organizations.

In his role on the Board, Mr. Achtmeyer supports Alira Health's emphasis on patient centricity and the structured involvement of patients in generating real-world evidence that informs regulatory strategy, market access, and commercial decision-making.

"I believe Gab is a trailblazer in this industry and has the passion and smarts to make Alira Health's value proposition into a sustainable competitive advantage," said Bill Achtmeyer.

Mr. Montgomery brings extensive experience across investment banking, operating leadership, and healthcare investing. He previously served as a Managing Director at JPMorgan H&Q and Cowen, held Board and Chief Financial Officer roles as a startup entrepreneur, and worked in private equity and venture capital investing at Gurnet Point Capital and WestRiver Group. As Chairman of the Board, Mr. Montgomery contributes strategic perspective focused on the quality, integration, and continuity of Alira Health's services across consulting, evidence generation, and CRO capabilities.

"Alira Health has built a platform that delivers consistently high-quality services across multiple disciplines," said George G. Montgomery. "The company's integrated model and focus on execution position it well to support clients across increasingly complex development and commercialization environments."

"We are pleased to have Bill and George serving on our Board," said Gabriele Brambilla, Chief Executive Officer of Alira Health. "Their perspectives align closely with our mission and are particularly valuable as we continue to scale our Patient-Enabled Solutions, integrating real-world insight into evidence generation, development strategy, access planning, and commercialization to better support our clients and the communities they serve."

Their participation further strengthens Alira Health's governance as the company continues to support life sciences organizations from early development through launch and commercialization.

About Alira Health

Alira Health is a global healthcare consultancy redefining evidence generation through patient partnership. By uniting strategic consulting, CRO services, and technology, the company supports life sciences organizations in accelerating development, improving access, and delivering measurable outcomes across the product lifecycle. To learn more about Alira Health, please visit alirahealth.com (https://alirahealth.com/).



Alira Health: Susan Irving - susan.irving@alirahealth.com

© 2026 GlobeNewswire (Europe)
Gold & Silber auf Rekordjagd
Kaum eine Entwicklung war 2025 so eindrucksvoll wie der Höhenflug der Edelmetalle. Allen voran Silber: Angetrieben von einem strukturellen Angebotsdefizit, explodierte der Preis und übertrumpfte dabei den „großen Bruder“ Gold. Die Nachfrage aus dem Investmentsektor zieht weiter an, und ein Preisziel von 100 US-Dollar rückt in greifbare Nähe.

Auch Gold markierte neue Meilensteine. Mit dem Durchbruch über 3.000 und 4.000 US-Dollar pro Unze hat sich der übergeordnete Aufwärtstrend eindrucksvoll bestätigt. Rücksetzer bleiben möglich, doch der nächste Zielbereich bei 5.000 US-Dollar ist charttechnisch fest im Blick. Die fundamentalen Treiber sind intakt, eine nachhaltige Trendwende aktuell nicht in Sicht.

Für Anlegerinnen und Anleger bedeutet das: Jetzt ist die Zeit, um gezielt auf starke Produzenten zu setzen. In unserem neuen Spezialreport stellen wir fünf Gold- und Silberaktien vor, die trotz Rallye weiter attraktives Potenzial bieten, mit robusten Fundamentaldaten und starken Projekten in aussichtsreichen Regionen.

Jetzt den kostenlosen Report sichern und von der nächsten Welle im Edelmetall-Boom profitieren!

Dieses exklusive PDF ist nur für kurze Zeit verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.